SCHEMBL7654557

SCHEMBL7654557

CC(=O)ON=C(N)NNC(=O)c1ccccc1O.Cn1c(=O)n2c(=O)c3c1ncn3C2

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.35
CA9 Q16790 1/20 0.35
TSHR P16473 1/20 0.34
L1CAM P32004 1/20 0.32
RXFP1 Q9HBX9 2/20 0.32
ALDH1A1 P00352 1/20 0.32
ADORA2B P29275 3/20 0.32
LMNA P02545 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
POLB P06746 1/20 0.31
NPC1 O15118 1/20 0.31
ALOX15 P16050 1/20 0.31
TRPA1 O75762 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aspirin SCHEMBL5467455 0.72 KDM4E (0.49) TSHRRXFP1ALDH1A1ADORA2BLMNA
SCHEMBL5469110 0.61 NPC1 (0.47) ALDH1A1LMNAKDM4EPOLBNPC1
SCHEMBL684044 0.60 ADORA2B (0.49) TSHRRXFP1ALDH1A1ADORA2BLMNA
SCHEMBL4453355 0.60 ADORA2B (0.49) TSHRRXFP1ADORA2BLMNAPOLB
Caffeine SCHEMBL2468803 0.60 ADORA2B (0.59) TSHRRXFP1ALDH1A1ADORA2BLMNA
Caffeine SCHEMBL667174 0.60 ADORA2B (0.62) CA1CA9TSHRRXFP1ALDH1A1
SCHEMBL5430755 0.60 ADORA2B (0.48) TSHRRXFP1ADORA2BLMNAPOLB
SCHEMBL122391 0.60 ADORA2B (0.48) TSHRRXFP1ADORA2BLMNAPOLB
SCHEMBL122001 0.60 ADORA2B (0.48) TSHRRXFP1ADORA2BLMNAPOLB
SCHEMBL6636585 0.58 CA1 (0.79) CA1CA9TSHRL1CAMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413962-B1 ANESTHESIA AND TEMPERATURES REDUCTION; ALPHA-ADRENOCEPTOR AGONIST; RESTORATIVE TO CENTRAL NERVOUS SYSTEM, ESPECIALLY MOTOR AND SENSORY FUNCTIONAL LOSSES FROM TRAMATIC SPINAL CORD INJURIES; ANTISPASTICS; NONSEDATIVE; SIDE EFFECT REDUCTION NAFTCHI N ERIC (US) 2002-07-02 US disclosed